Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy

    ... analysis, adverse cytogenetics , excess of blasts at the initiation of LEN, and the type of failure (classified as ...

    Research Article last updated 02/21/2017 - 9:43am.

  2. Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial

    ... in patients with myelodysplastic syndromes with excess blasts after failure of azacitidine or decitabine ... with diagnosis of refractory anaemia with excess blasts (RAEB)-1, RAEB-2, RAEB-t, or chronic myelomonocytic leukaemia based on ...

    Research Article last updated 06/07/2016 - 11:10am.

  3. Are Myelodysplastic Syndromes Underdiagnosed in Poland? A Report by the Polish Adult Leukaemia Group

    ... with MDS and acute myeloid leukaemia (AML) with 20-29% blasts were enrolled. Data collection was conducted for strictly predefined ...

    Research Article last updated 11/02/2016 - 10:17am.

  4. Retired MDS Patient Living Life to the Fullest Since Transplant

    ... stage was Refractory Anemia with Excess Blasts (RAEB-1) with one chromosomal abnormality. In February 2010, I ...

    Patient Chronicle last updated 04/26/2018 - 10:43am.

  5. Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes

    ... to patients with refractory anaemia with excess blasts (RAEB). In 2025 HMA-treated patients, median survival was 15 months ...

    Research Article last updated 10/06/2016 - 11:34am.

  6. TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

    ... 53 (46%) had bone marrow blast clearance (<5% blasts ). Response rates were higher among patients with an unfavorable-risk ...

    Research Article last updated 01/26/2017 - 10:07am.

  7. Myelodysplastic syndromes: Contemporary review and how we treat

    ... peripheral blood and bone marrow dysplasia/ blasts , and clonal cytogenetic abnormalities. With the advent of next ...

    Research Article last updated 04/29/2016 - 1:05pm.

  8. A Meta-Analysis of the Relationship between Cigarette Smoking and Incidence of Myelodysplastic Syndromes.

    ... with ringed sideroblasts (RARS) or RA with excess blasts (RAEB)/RAEB in transformation (RAEBt), respectively. Our results ...

    Research Article last updated 04/29/2016 - 12:57pm.

  9. Personalized medicine for MDS

    ... who does not require transfusions, has no increase in blasts , nor any poor-risk cytogenetic abnormalities. These patients, ...

    Research Review last updated 05/02/2016 - 9:44am.

  10. Myeloablative Unrelated Donor Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies

    ... or relapse/ refractory less than or equal to 10% blasts in bone marrow , or aplasia post-therapy. This includes ... in CR, or relapse with less than or equal 10% bone marrow blasts. CML with tyrosine kinase inhibitor failure in chronic or ...

    Clinical Trial last updated 04/29/2016 - 1:33pm.